Steven R Laviolette
Overview
Explore the profile of Steven R Laviolette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
2263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Chen C, Laviolette S, Whitehead S, Renaud J, Yeung K
J Am Soc Mass Spectrom
. 2021 Mar;
32(4):1065-1079.
PMID: 33783203
Inorganic nanostructured materials such as silicon, carbon, metals, and metal oxides have been explored as matrices of low-background signals to assist the laser desorption/ionization (LDI) mass spectrometric (MS) analysis of...
22.
OSullivan S, Stevenson C, Laviolette S
Cannabis Cannabinoid Res
. 2021 Feb;
6(1):7-18.
PMID: 33614948
Coronavirus disease-19 (COVID-19)-related anxiety and post-traumatic stress symptoms (PTSS) or post-traumatic stress disorder (PTSD) are likely to be a significant long-term issue emerging from the current pandemic. We hypothesize that...
23.
Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
Nashed M, Hardy D, Laviolette S
Front Psychiatry
. 2021 Feb;
11:624275.
PMID: 33519564
Clinical reports of cannabis use prevalence during pregnancy vary widely from 3% to upwards of 35% in North America; this disparity likely owing to underestimates from self-reporting in many cases....
24.
De Felice M, Renard J, Hudson R, Szkudlarek H, Pereira B, Schmid S, et al.
J Neurosci
. 2020 Dec;
41(4):739-750.
PMID: 33268546
Chronic adolescent exposure to Δ-9-tetrahydrocannabinol (THC) is linked to elevated neuropsychiatric risk and induces neuronal, molecular and behavioral abnormalities resembling neuropsychiatric endophenotypes. Previous evidence has revealed that the mesocorticolimbic circuitry,...
25.
Laviolette S
Neuropharmacology
. 2020 Nov;
184:108411.
PMID: 33245960
Tobacco addiction is highly co-morbid with a variety of mental health conditions, including schizophrenia, mood and anxiety disorders. Nicotine, the primary psychoactive compound in tobacco-related products is known to functionally...
26.
Jung T, Hudson R, Rushlow W, Laviolette S
Eur J Neurosci
. 2020 Oct;
55(4):1088-1100.
PMID: 33108021
Cannabis contains a plethora of phytochemical constituents with diverse neurobiological effects. Cannabidiol (CBD) is the main non-psychotropic component found in cannabis that is capable of modulating mesocorticolimbic DA transmission and...
27.
Szkudlarek H, Rodriguez-Ruiz M, Hudson R, De Felice M, Jung T, Rushlow W, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2020 Jul;
104:110029.
PMID: 32623021
Clinical and pre-clinical evidence demonstrates divergent psychotropic effects of THC vs. CBD. While THC can induce perceptual distortions and anxiogenic effects, CBD displays antipsychotic and anxiolytic properties. A key brain...
28.
Gillies R, Lee K, Vanin S, Laviolette S, Holloway A, Arany E, et al.
Reprod Toxicol
. 2020 Apr;
94:84-91.
PMID: 32325173
Recent reports indicate that 7% of pregnant mothers in North America use cannabis. This is concerning given that in utero exposure to Δ9-tetrahydrocannabinol (Δ9-THC), the main psychoactive component in cannabis,...
29.
Hudson R, Green M, Wright D, Renard J, Jobson C, Jung T, et al.
Addict Biol
. 2020 Mar;
26(2):e12891.
PMID: 32135573
Long-term tobacco dependence typically develops during adolescence and neurodevelopmental nicotine exposure is associated with affective disturbances that manifest as a variety of neuropsychiatric comorbidities in clinical and preclinical studies, including...
30.
Natale B, Gustin K, Lee K, Holloway A, Laviolette S, Natale D, et al.
Sci Rep
. 2020 Jan;
10(1):544.
PMID: 31953475
1 in 5 women report cannabis use during pregnancy, with nausea cited as their primary motivation. Studies show that (-)-△9-tetrahydrocannabinol (Δ9-THC), the major psychoactive ingredient in cannabis, causes fetal growth...